These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15508021)

  • 1. Mu-opioid self-administration vs passive administration in heroin abusers produces differential EEG activation.
    Greenwald MK; Roehrs TA
    Neuropsychopharmacology; 2005 Jan; 30(1):212-21. PubMed ID: 15508021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid craving and seeking behavior in physically dependent volunteers: effects of acute withdrawal and drug reinforcement opportunity.
    Greenwald MK
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):3-14. PubMed ID: 15727498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers.
    Comer SD; Collins ED
    J Pharmacol Exp Ther; 2002 Nov; 303(2):695-703. PubMed ID: 12388653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
    Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
    J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regional effects of methadone maintenance compared to heroin dependence on mu-opioid receptor desensitization in rat brain.
    Martin TJ; Kahn WR; Xiao R; Childers SR
    Synapse; 2007 Mar; 61(3):176-84. PubMed ID: 17152089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of buprenorphine on fentanyl withdrawal in rats.
    Bruijnzeel AW; Marcinkiewcz C; Isaac S; Booth MM; Dennis DM; Gold MS
    Psychopharmacology (Berl); 2007 May; 191(4):931-41. PubMed ID: 17211652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid receptor regulation in mice.
    Yoburn BC; Billings B; Duttaroy A
    J Pharmacol Exp Ther; 1993 Apr; 265(1):314-20. PubMed ID: 8386239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative clinical pharmacology of short-acting mu opioids in drug abusers.
    Greenwald MK; June HL; Stitzer ML; Marco AP
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1228-36. PubMed ID: 8667183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice.
    Waxman AR; Arout C; Caldwell M; Dahan A; Kest B
    Neurosci Lett; 2009 Oct; 462(1):68-72. PubMed ID: 19559072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study.
    Zubieta J; Greenwald MK; Lombardi U; Woods JH; Kilbourn MR; Jewett DM; Koeppe RA; Schuster CR; Johanson CE
    Neuropsychopharmacology; 2000 Sep; 23(3):326-34. PubMed ID: 10942856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor.
    Cox EH; Kerbusch T; Van der Graaf PH; Danhof M
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1095-103. PubMed ID: 9495871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites.
    Dardonville C; Fernandez-Fernandez C; Gibbons SL; Ryan GJ; Jagerovic N; Gabilondo AM; Meana JJ; Callado LF
    Bioorg Med Chem; 2006 Oct; 14(19):6570-80. PubMed ID: 16797997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
    Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J
    Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
    Picker MJ; Cook CD
    Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteral naloxone reduces gastric tube reflux and frequency of pneumonia in critical care patients during opioid analgesia.
    Meissner W; Dohrn B; Reinhart K
    Crit Care Med; 2003 Mar; 31(3):776-80. PubMed ID: 12626983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.